With the Renaissance system already in use at leading U.S. hospitals specializing in spine surgery, this is the first Renaissance system installed in an ambulatory surgery center. According to National Health Statistic Reports, more than 300,000 people in the U.S. seek surgery annually for relief from chronic back pain resulting from spinal disc diseases, including herniations and protrusions. Common spine procedures such as endoscopic discectomy are typically performed in spine surgery centers while other procedures such as spinal fusion are usually performed in hospitals. With new technology like the Renaissance system, more cases can be performed on an out-patient basis with minimal recovery time. There are approximately 3,300 ambulatory surgery centers in the U.S.
"Our clinical experiences with Mazor Robotics technology, including examination of numerous peer-reviewed studies and hands-on demonstrations, has convinced us to add Renaissance to our surgical program," said Ms. Jennifer Butterfield, CEO of Lakes Surgery Center. "We believe that Mazor Robotics Renaissance system will differentiate our facility by enabling us to raise the level of patient care, for spinal endoscopy as well as for other spine procedures."
"Many of my spine surgery referrals are for spinal endoscopy procedures," said Kevin Lee, MD, a leading neurosurgeon and pain management / spinal endoscopy specialist at Lakes Surgery Center. "Demand for minimally invasive surgery has grown dramatically in recent years, and as technology advances we see improvement in patient outcomes. We recognize the tremendous potential of Renaissance; it is the next step in the evolution of incorporating state-of-the-art technology for better patient care. Mazor Robotics technology will take these procedures to the next level by providing a safer and more accurate way to enter the surgical site, reduce intra-operative radiation, shorten procedure time, and reduce complications."
"This purchase agreement with NSH Michigan, Inc. is strategically important for Mazor Robotics as it significantly expands our market opportunity to include ambulatory surgery centers in the U.S.," said Ori Hadomi, CEO of Mazor Robotics. "We are also excited about the clinical opportunity this represents, as many more patients will now have access to such minimally invasive procedures."
About Mazor Robotics
Mazor Robotics Ltd (TASE: MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and OR staff. Mazor Robotics flagship product, Renaissance™, is a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 15,000 implants in the USA and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, visit www.mazorrobotics.com.
Posted by Sean Fenske, Editor-in-Chief, MDT